Results 131 to 140 of about 19,007 (183)

Tumour-Induced Osteomalacia in Metastatic Prostate Carcinoma: The Rest of the Story. [PDF]

open access: yesIndian J Endocrinol Metab
Varghese SK   +3 more
europepmc   +1 more source

Fibroblast growth factor 23: Regulation, signalling and systemic links between bone, metabolism and inflammation. [PDF]

open access: yesMol Metab
Crespo-Golmar A   +9 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Osteomalacia

Vnitřní lékařství, 2023
Osteomalacia with characteristic histomorphometric, radiographic, laboratory and clinical features is a prominent syndrome of disturbed bone mineralisation in adulthood. From an etiological point of view, osteomalacia is usually caused by substrate (calcium, phosphate) deficiency, presence of excess mineralization inhibitors or deficiency or ...
openaire   +2 more sources

Osteomalacia

Baillière's Clinical Endocrinology and Metabolism, 1997
Osteomalacia is a generalized bone disorder characterized by impairment of mineralization, leading to accumulation of unmineralized matrix or osteoid in the skeleton. The classical clinical features of osteomalacia include musculoskeletal pain, skeletal deformity, muscle weakness and symptomatic hypocalcaemia.
R M, Francis, P L, Selby
openaire   +2 more sources

Oncogenic Osteomalacia

Seminars in Musculoskeletal Radiology, 2002
Oncogenic osteomalacia is a rare paraneoplastic syndrome caused by bone and soft tissue tumors. The characteristic clinical, metabolic, and imaging findings are reviewed, as is the radiologist's role in evaluation and diagnosis. New insight into the pathophysiology of oncogenic osteomalacia is also presented.
Kelli Andresen, Edmister   +1 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy